238 related articles for article (PubMed ID: 34325969)
1. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
[TBL] [Abstract][Full Text] [Related]
2. Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study.
Kamali I; Shumbusho F; Barnhart DA; Nyirahabihirwe F; Gakuru JP; Dusingizimana W; Nizeyumuremyi E; Habinshuti P; Walker S; Makuza JD; Serumondo J; Nshogoza Rwibasira G; Ndahimana JD
BMC Infect Dis; 2022 Mar; 22(1):272. PubMed ID: 35313817
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
[TBL] [Abstract][Full Text] [Related]
5. On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era.
Busschots D; Bielen R; Koc ÖM; Heyens L; Dercon E; Verrando R; Janssens F; Van den Bergh L; Van Lint P; Bruckers L; Nevens F; Robaeys G
BMC Public Health; 2021 Aug; 21(1):1574. PubMed ID: 34416867
[TBL] [Abstract][Full Text] [Related]
6. Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol.
Klaman SL; Godino JG; Northrup A; Lewis SV; Tam A; Carrillo C; Lewis R; Matthews E; Mendez B; Reyes L; Rojas S; Ramers C
BMC Infect Dis; 2024 Jan; 24(1):105. PubMed ID: 38238686
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
[TBL] [Abstract][Full Text] [Related]
8. Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient-centered program from Italy.
Mangia A; Rina MF; Canosa A; Piazzolla V; Squillante MM; Agostinacchio E; Cocomazzi G; Visaggi E; Augello N; Iannuzziello C; Falcone M; De Giorgi A; Campanozzi F
United European Gastroenterol J; 2021 Dec; 9(10):1109-1118. PubMed ID: 34697911
[TBL] [Abstract][Full Text] [Related]
9. Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada.
Wolfson-Stofko B; Hirode G; Vanderhoff A; Karkada J; Capraru C; Biondi MJ; Hansen B; Shah H; Janssen HLA; Feld JJ
J Viral Hepat; 2024 May; 31(5):240-247. PubMed ID: 38385850
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.
Herink MC; Seaman A; Leichtling G; Larsen JE; Gailey T; Cook R; Thomas A; Korthuis PT
Addict Sci Clin Pract; 2023 May; 18(1):35. PubMed ID: 37245041
[TBL] [Abstract][Full Text] [Related]
11. Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C.
Conti J; Dryden E; Fincke BG; Dunlap S; McInnes DK
J Gen Intern Med; 2023 Jan; 38(1):156-164. PubMed ID: 35879538
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
[TBL] [Abstract][Full Text] [Related]
13. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.
Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN
Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152
[TBL] [Abstract][Full Text] [Related]
14. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
Bartlett SR; Wong S; Yu A; Pearce M; MacIsaac J; Nouch S; Adu P; Wilton J; Samji H; Clementi E; Velasquez H; Jeong D; Binka M; Alvarez M; Wong J; Buxton J; Krajden M; Janjua NZ
Clin Infect Dis; 2022 Mar; 74(4):575-583. PubMed ID: 34125883
[TBL] [Abstract][Full Text] [Related]
16. Statewide Assessment of the Hepatitis C Virus Care Cascade for Incarcerated Persons in Vermont.
Hale AJ; Mathur S; Dejace J; Lidofsky SD
Public Health Rep; 2023; 138(2):265-272. PubMed ID: 35264027
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Mabileau G; Dhersin JS; Yazdanpanah Y
J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211
[TBL] [Abstract][Full Text] [Related]
18. Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study).
Rolland B; Lions C; Di Beo V; Carrieri P; Authier N; Barré T; Delorme J; Mathurin P; Bailly F; Protopopescu C; Marcellin F
Harm Reduct J; 2022 Oct; 19(1):119. PubMed ID: 36303159
[TBL] [Abstract][Full Text] [Related]
19. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I
Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C care cascade in a large academic healthcare system, 2012 to 2018.
Nakayama J; Hertzberg VS; Ho JC; Simpson RL; Cartwright EJ
Medicine (Baltimore); 2023 Mar; 102(10):e32859. PubMed ID: 36897716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
